PET Imaging of the Neuropeptide Y System: A Systematic Review.

Neuropeptide Y / metabolism Positron-Emission Tomography Receptors, Neuropeptide Y / chemistry
NPY receptors PET radiotracers neuroimaging neuropeptide Y positron emission tomography

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
09 Jun 2022
Historique:
received: 02 05 2022
revised: 03 06 2022
accepted: 05 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Neuropeptide Y (NPY) is a vastly studied biological peptide with numerous physiological functions that activate the NPY receptor family (Y

Identifiants

DOI: 10.3390/molecules27123726 PMID: 35744852 PMC: PMC9227365
pubmed: 35744852
pii: molecules27123726
doi: 10.3390/molecules27123726
pmc: PMC9227365
pii:
doi:

Substances chimiques

Neuropeptide Y 0
Receptors, Neuropeptide Y 0

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fundação para a Ciência e Tecnologia
ID : UIDB/04539/2020, UIDP/04539/2020, UIDB/4950/2020, UIDP/4950/2020, PD/BDE/150334/2019

Références

Psychopharmacology (Berl). 2010 Feb;208(2):265-77
pubmed: 19953226
FEBS Lett. 1995 Apr 3;362(2):192-6
pubmed: 7720871
J Clin Endocrinol Metab. 2001 Dec;86(12):5956-63
pubmed: 11739470
Eur J Pharmacol. 2008 Dec 28;601(1-3):1-7
pubmed: 18976648
Bioorg Med Chem Lett. 2010 Dec 15;20(24):7341-4
pubmed: 21074426
Peptides. 2000 Mar;21(3):393-9
pubmed: 10793222
J Recept Signal Transduct Res. 2007;27(4):217-33
pubmed: 17885919
J Med Chem. 2001 May 10;44(10):1479-82
pubmed: 11334558
Br J Pharmacol. 1999 Feb;126(4):989-96
pubmed: 10193779
ACS Chem Neurosci. 2016 May 18;7(5):540-5
pubmed: 26886507
Pharmacol Rev. 1998 Mar;50(1):143-50
pubmed: 9549761
Pharmacol Ther. 2011 Jul;131(1):91-113
pubmed: 21439311
J Clin Pharmacol. 2001 May;41(5):482-91
pubmed: 11361044
Nature. 2001 Jan 25;409(6819):513-7
pubmed: 11206547
Neurosci Lett. 2002 Oct 25;332(1):1-4
pubmed: 12377370
Sci Rep. 2019 Sep 10;9(1):12990
pubmed: 31506520
Neurosci Lett. 2005 Jan 20;373(3):175-8
pubmed: 15619538
J Pharmacol Exp Ther. 2009 Mar;328(3):900-11
pubmed: 19098165
Clin Pharmacokinet. 2002;41(8):581-602
pubmed: 12102642
EMBO Mol Med. 2010 Nov;2(11):429-39
pubmed: 20972986
Eur J Pharmacol. 2001 Apr 20;418(1-2):95-104
pubmed: 11334870
Neuropeptides. 2016 Feb;55:99-109
pubmed: 26441327
J Med Chem. 1996 Mar 1;39(5):1142-7
pubmed: 8676351
Biol Chem. 2013 Aug;394(8):921-36
pubmed: 23449522
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Peptides. 2002 Feb;23(2):359-65
pubmed: 11825650
Bioorg Med Chem Lett. 2009 Sep 15;19(18):5436-9
pubmed: 19679469
J Cereb Blood Flow Metab. 2012 Jul;32(7):1426-54
pubmed: 22434067
Nucl Med Biol. 2008 Nov;35(8):805-15
pubmed: 19026942
Peptides. 2010 Sep;31(9):1706-10
pubmed: 20600429
Brain Res Mol Brain Res. 1994 Oct;26(1-2):320-4
pubmed: 7854062
Endocr Dev. 2014;27:63-75
pubmed: 25247645
J Clin Endocrinol Metab. 2003 Aug;88(8):3989-92
pubmed: 12915697
Eur J Neurosci. 1999 Apr;11(4):1431-48
pubmed: 10103138
J Clin Invest. 1998 Dec 15;102(12):2136-45
pubmed: 9854049
Nature. 1982 Apr 15;296(5858):659-60
pubmed: 6896083
Nature. 1983 Dec 8-14;306(5943):584-6
pubmed: 6358901
Mol Pharmacol. 2001 Mar;59(3):501-5
pubmed: 11179445
Bioorg Med Chem. 2004 Jan 15;12(2):507-21
pubmed: 14723969
Bioorg Med Chem Lett. 2004 Mar 8;14(5):1239-42
pubmed: 14980673
Bioorg Med Chem Lett. 2002 Jul 8;12(13):1767-9
pubmed: 12067557
Mol Pharmacol. 2010 Jan;77(1):46-57
pubmed: 19837904
Eur J Biochem. 2001 May;268(10):2828-37
pubmed: 11358498
Int J Obes Relat Metab Disord. 2004 Apr;28(4):628-39
pubmed: 14758341
Peptides. 2000 Oct;21(10):1565-82
pubmed: 11068106
Bioorg Med Chem. 2009 Oct 1;17(19):6971-82
pubmed: 19720539
Proc Natl Acad Sci U S A. 1990 Jan;87(1):182-6
pubmed: 2153286
Neuroscience. 1998 Nov;87(1):289-302
pubmed: 9722158
Nature. 1996 Jul 11;382(6587):168-71
pubmed: 8700207
J Pharmacol Exp Ther. 2006 May;317(2):562-70
pubmed: 16436501
Endocrinology. 1992 Jun;130(6):3323-30
pubmed: 1317781
Pharmaceuticals (Basel). 2018 Jul 04;11(3):
pubmed: 29973529
ILAR J. 2001;42(3):219-32
pubmed: 11406721
J Neurosci. 2002 Feb 1;22(3):RC208
pubmed: 11826154
Bioorg Med Chem Lett. 2002 Feb 11;12(3):379-82
pubmed: 11814801
Mol Pharm. 2014 Feb 3;11(2):505-15
pubmed: 24325589
Peptides. 2001 Mar;22(3):473-81
pubmed: 11287104
Peptides. 2001 Mar;22(3):483-91
pubmed: 11287105
Regul Pept. 1995 Oct 20;59(2):201-5
pubmed: 8584755
Bioorg Med Chem Lett. 2012 Jun 15;22(12):3916-20
pubmed: 22607676
Peptides. 1998;19(3):537-42
pubmed: 9533642
ChemMedChem. 2020 Sep 3;15(17):1652-1660
pubmed: 32681597
J Am Chem Soc. 2015 Feb 4;137(4):1548-55
pubmed: 25569730
Cancer Res. 2001 Jun 1;61(11):4636-41
pubmed: 11389101
J Pept Sci. 2000 Mar;6(3):97-122
pubmed: 10759209
J Nucl Med. 2014 Apr;55(4):635-9
pubmed: 24614224
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5124-7
pubmed: 19640706
J Med Chem. 1997 Nov 7;40(23):3712-4
pubmed: 9371234
J Neurosci. 2003 Feb 15;23(4):1487-97
pubmed: 12598637
Regul Pept. 2002 Jun 15;106(1-3):47-54
pubmed: 12047910
Bioorg Med Chem Lett. 2009 Aug 1;19(15):4022-5
pubmed: 19581086
Neurobiol Dis. 2014 Jan;61:32-8
pubmed: 24055214
Eur J Pharmacol. 1994 Dec 27;271(2-3):R11-3
pubmed: 7705422
FEBS Lett. 1996 Feb 26;381(1-2):58-62
pubmed: 8641440
J Biol Chem. 1990 Jul 15;265(20):11706-12
pubmed: 2164012
Nature. 2002 Aug 8;418(6898):650-4
pubmed: 12167864
Br J Pharmacol. 1998 Aug;124(7):1507-15
pubmed: 9723965
Alcohol Clin Exp Res. 2003 Dec;27(12):1884-91
pubmed: 14691375
Neuroimage. 2011 Feb 14;54(4):2635-42
pubmed: 21078401
ChemMedChem. 2013 Apr;8(4):587-93
pubmed: 23361914
Proc Soc Exp Biol Med. 1993 Jan;202(1):44-63
pubmed: 8380927
J Neurochem. 1999 Aug;73(2):641-6
pubmed: 10428060
Endocrinology. 2000 Mar;141(3):1011-6
pubmed: 10698177
Nat Rev Drug Discov. 2003 Feb;2(2):123-31
pubmed: 12563303
Cell Metab. 2006 Oct;4(4):275-82
pubmed: 17011500
Neurobiol Dis. 2016 Nov;95:210-24
pubmed: 27461050
Neuropeptides. 2004 Aug;38(4):163-74
pubmed: 15337369
Br J Pharmacol. 2008 Feb;153(3):420-31
pubmed: 17828288
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9067-71
pubmed: 7568074
Bone. 2016 Mar;84:139-147
pubmed: 26721736
Mol Pharm. 2015 Apr 6;12(4):1121-30
pubmed: 25748228
Science. 1983 Aug 26;221(4613):877-9
pubmed: 6136091
J Neurosci. 1999 Dec 1;19(23):10295-304
pubmed: 10575027
J Med Chem. 2006 Apr 20;49(8):2661-5
pubmed: 16610810
Br J Pharmacol. 2003 Aug;139(7):1360-8
pubmed: 12890716
J Comp Neurol. 2005 Feb 14;482(3):217-43
pubmed: 15690487
J Mol Neurosci. 2004;22(3):159-66
pubmed: 14997009
J Biol Chem. 1997 Mar 21;272(12):7699-706
pubmed: 9065428
Peptides. 2002 Aug;23(8):1485-90
pubmed: 12182951
J Pharmacol Exp Ther. 1992 Dec;263(3):1212-8
pubmed: 1469629
Br J Pharmacol. 1997 Feb;120(3):481-7
pubmed: 9031753
Eur J Pharmacol. 2008 Aug 20;590(1-3):224-32
pubmed: 18573246
Eur J Pharmacol. 1998 May 15;349(1):97-105
pubmed: 9669502
Chem Biol Drug Des. 2021 Jul;98(1):182-191
pubmed: 33982434
Bioorg Med Chem Lett. 2002 Apr 8;12(7):1009-11
pubmed: 11909705
EJNMMI Radiopharm Chem. 2019 Feb 18;4(1):4
pubmed: 31659508
J Biol Chem. 1996 Nov 1;271(44):27217-20
pubmed: 8910290
J Comp Neurol. 1998 Dec 21;402(3):372-84
pubmed: 9853905
Regul Pept. 1996 Apr 9;62(1):1-11
pubmed: 8738876
Br J Clin Pharmacol. 2012 Feb;73(2):175-86
pubmed: 21838787
Biochem J. 2003 Feb 1;369(Pt 3):667-73
pubmed: 12398768
Org Biomol Chem. 2011 May 7;9(9):3313-9
pubmed: 21437342
ACS Med Chem Lett. 2017 Feb 21;8(3):304-309
pubmed: 28337321
Biochem Biophys Res Commun. 2000 May 27;272(1):169-73
pubmed: 10872822
J Med Chem. 1996 Feb 16;39(4):811-3
pubmed: 8632403
Eur J Pharmacol. 1999 Nov 19;384(2-3):R3-5
pubmed: 10611450
FEBS Lett. 1996 Sep 30;394(2):169-73
pubmed: 8843157
J Biol Chem. 2000 Nov 17;275(46):36043-8
pubmed: 10944518
Behav Pharmacol. 1995 Apr;6(3):215-222
pubmed: 11224329
Alcohol Clin Exp Res. 2004 Sep;28(9):1324-30
pubmed: 15365302
J Med Chem. 2002 Aug 1;45(16):3509-23
pubmed: 12139462
Proc Natl Acad Sci U S A. 1982 Sep;79(18):5485-9
pubmed: 6957876
Radiology. 2007 Oct;245(1):21-42
pubmed: 17885179
Biochem Biophys Res Commun. 1999 Dec 9;266(1):88-91
pubmed: 10581170
Br J Pharmacol. 1998 Oct;125(3):549-55
pubmed: 9806339
Neuropeptides. 2009 Dec;43(6):491-7
pubmed: 19781771
Cell Death Dis. 2013 May 16;4:e636
pubmed: 23681231
Regul Pept. 1998 Sep 25;75-76:71-8
pubmed: 9802395
Clin Chim Acta. 2002 Dec;326(1-2):3-25
pubmed: 12417094
Prog Neurobiol. 2014 Jan;112:70-9
pubmed: 24184719

Auteurs

Inês C F Fonseca (ICF)

CIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.
Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
ICNAS Pharma Unipessoal, Lda, Ed. ICNAS, Pólo das Ciências da Saúde, University of Coimbra, 3000-548 Coimbra, Portugal.

Miguel Castelo-Branco (M)

CIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.
ICNAS Pharma Unipessoal, Lda, Ed. ICNAS, Pólo das Ciências da Saúde, University of Coimbra, 3000-548 Coimbra, Portugal.
Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.

Cláudia Cavadas (C)

Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-531 Coimbra, Portugal.

Antero J Abrunhosa (AJ)

CIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.
ICNAS Pharma Unipessoal, Lda, Ed. ICNAS, Pólo das Ciências da Saúde, University of Coimbra, 3000-548 Coimbra, Portugal.
ORCID: 0000-0002-4145-854X

Articles similaires

Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation.

Mahsa Shanaki Bavarsad, Salvatore Spina, Abby Oehler et al.
1.00
Humans Synaptophysin Aged Female Positron-Emission Tomography

Predictive value of metabolic parameters and apparent diffusion coefficient derived from 18F-FDG PET/MR in patients with non-small cell lung cancer.

Han Jiang, Ziqiang Li, Nan Meng et al.
1.00
Humans Carcinoma, Non-Small-Cell Lung Fluorodeoxyglucose F18 Male Lung Neoplasms

Critical assessment of anti-amyloid-β monoclonal antibodies effects in Alzheimer's disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness.

Konstantinos I Avgerinos, Apostolos Manolopoulos, Luigi Ferrucci et al.
1.00
Alzheimer Disease Humans Amyloid beta-Peptides Antibodies, Monoclonal Positron-Emission Tomography

[

Myriam El Biali, Louise Breuil, Matthias Jackwerth et al.
1.00
Humans Positron-Emission Tomography Male Adult Female

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de tissu nerveux › Neuropeptides › Neuropeptide Y › PET Imaging of the Neuropeptide Y System: A...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › PET Imaging of the Neuropeptide Y System: A...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur aux neuropeptides › Récepteur neuropeptide Y › PET Imaging of the Neuropeptide Y System: A...